Comparative Cost-Effectiveness of Advanced Treatment Sequences for Moderately to Severely Active Ulcerative Colitis in Japan.

Remicade (infliximab) - J&J

Stelara (ustekinumab) - J&J

Rinvoq (upadacitinib) - AbbVie

Velsipity (etrasimod) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42709323

Akira Yuasa; Ernest H Law; Hiroyuki Matsuda; Katsuya Yamagami; Kazumasa Kamei; Masato Hoshi; Miwa Enami; Yawen Dai

Sep 9, 2026